Non-Alcoholic Steatohepatitis (NASH) treatment market registers fastest CAGR among liver diseases

The Non-Alcoholic Steatohepatitis (NASH) treatment market is set to grow rapidly. It is expected to rise from US$ 7.9 billion in 2024 to about US$ 94.0 billion by 2034, growing at a CAGR of 28.1% during the forecast period. View more: https://market.us/report/non-alcoholic-steatohepatitis-treatment-market/